The Healthcare Plastics Recycling Council (HPRC) is pleased to welcome Terumo Corporation, a global medical technology company that develops, manufactures, and distributes medical devices and solutions, as a new member.
"Terumo's advanced expertise in medical plastics, from design and manufacturing to design-for-recyclability, will add meaningful capability to HPRC's technical coalition," said Tracy Taszarek, Executive Director of HPRC. "We're pleased to welcome Terumo as a new member and look forward to their contributions to our project work."
With operations in more than 160 countries and regions, Terumo is a global leader in healthcare innovation. Terumo is committed to sustainability, implementing initiatives to reduce its environmental footprint, promote resource efficiency, and support circularity in medical plastics.
"Joining HPRC supports our ongoing work to promote responsible resource use, protect the environment, and transition to circular healthcare plastics," shared Emiko Kawamura, General Manager, EHS Management Department for Terumo. "We look forward to collaborating with fellow HPRC members to continue developing innovative solutions and learning from their valuable insights as industry leaders."
HPRC is currently engaged in multiple initiatives aimed at enabling the recycling and circularity of healthcare plastics, including an assessment of recycling infrastructure, opportunities for labelling standardization, and developing a scalable playbook for implementing regional hospital recycling programs.
About HPRC
HPRC is a private technical coalition of industry peers across healthcare, recycling, and waste management industries seeking to improve the recyclability of plastic products within healthcare. Made up of more than 30 brand-leading and globally recognized members, HPRC explores ways to enhance the economics, efficiency, and ultimately the quality and quantity of healthcare plastics collected for recycling in support of a circular plastics economy. HPRC is active across the United States and Europe working with key stakeholders, identifying opportunities for collaboration, and participating in industry events and forums. For more information, visit www.hprc.org and follow HPRC on LinkedIn.
About Terumo Corporation
Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of "Contributing to Society through Healthcare." Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
